Mayne slides to two-and-a-half year low as generics take toll
MELBOURNE: Specialty pharmaceutical company Mayne Pharma is the biggest loser among the top 200 stocks,
MELBOURNE: Specialty pharmaceutical company Mayne Pharma is the biggest loser among the top 200 stocks,
FEATURED
Special research team creates ‘predictive medicine’ AI tool
Gen Z fear they will be poorest generation
New development earmarked for hospitality and multigenerational living
Public notification opens for 25-unit project on former landfill
Nine-story homeless tower rejected by council in shock vote
Multigenerational affordable housing planned for regeneration site
INNOVATION
